Navigation Links
Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
Date:8/21/2008

LAKE FOREST, Ill., Aug. 21 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced new national agreements with Premier Purchasing Partners. The multi-year contracts will provide Premier's 2,000 member hospitals with access to special pricing and terms pre-negotiated by Premier for Hospira's general-purpose medication infusion devices, related sets and disposables, along with intravenous (I.V.) solutions, nutritionals, drug-delivery and gravity administration sets. The five-year Premier agreements will be effective February 1, 2009.

"Premier shares our commitment to improving patient and caregiver safety, while reducing the high costs of healthcare," said Pete Baker, vice president and general manager, Commercial Service Operations, Hospira. "Hospira products and services are well positioned to deliver positive results in these critical areas for the Premier membership. We look forward to collaborating with Premier's member healthcare institutions to provide innovative solutions and drive results."

The new agreements include Hospira's general-purpose medication management technologies, such as the Plum A+(R) and next-generation Symbiq(R) infusion systems with Hospira MedNet(R) safety software; and pain management pumps, such as LifeCare PCA(R) with Hospira MedNet and GemStar(R) ambulatory devices. These products play a critical role in improving patient safety as well as enhancing quality of care and clinician workflow. Also covered within the agreement is access to contracts for Hospira's I.V. solutions and associated equipment portfolio, including the company's environmentally preferable VisIV(R) container. This represents the first opportunity
'/>"/>

SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Hospira Reports Second-Quarter 2008 Results
2. Hospira Hosts Conference Call for Second-Quarter 2008 Earnings
3. Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders
4. Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
5. Hospira Acquires Sculptor
6. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
7. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
8. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
9. Hospira Launches Generic Irinotecan Injection
10. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
11. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Finally a Health Care Option for Small Businesses 50925 1Finally a Health Care Option for Small Businesses 50925 22009 3A Immunotec announces important clinical research initiative 3A New study to be launched with the goal of improving the quality of the aging pro 12920 12009 3A Immunotec announces important clinical research initiative 3A New study to be launched with the goal of improving the quality of the aging pro 12920 22009 3A Immunotec announces important clinical research initiative 3A New study to be launched with the goal of improving the quality of the aging pro 12920 3Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 1Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 2Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 3Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 4